

Closing Bell: What’s Riding on Big Tech’s Big Reports? 10/29/24
Oct 29, 2024
Dan Greenhaus from Solus Alternative Asset Management, Courtney Garcia of Payne Capital Management, Brian Belski from BMO, Katherine Stueland, CEO of GeneDX, and Doug Clinton of Intelligent Alpha delve into the mega-cap tech landscape. They discuss the urgency surrounding Alphabet's upcoming earnings amid fierce competition and regulatory hurdles. Stueland also shares GeneDX's success in pediatric genetic diagnostics and their innovative approach to genetic testing. Insights into mid-cap investments and AI's impact on market dynamics provide listeners with valuable takeaways.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 1min
Navigating Alphabet's Earnings and Market Challenges
01:28 • 14min
Navigating Mid-Cap Investments
15:46 • 7min
Balancing Patient Care and Profitability in Healthcare
22:58 • 1min
Transforming Pediatric Healthcare with Genetic Testing
24:26 • 5min
AI and Earnings: Tech Titans' Next Moves
29:00 • 15min